 |
|
|
| |
BEAT2 PRIMARY TRIAL OUTCOMES: PEG-IFN-Α2B + 3BNC117 & 10-1074 IN CHRONIC HIV INFECTION
|
| |
| |
CROI 2023 Feb 20-23
Pablo Tebas 1, Livio Azzoni 2, Emmanouil Papasavvas 2, Grace Choi 1, Susan Ellenberg 1, Marina Caskey 3, Bonnie J. Howell 4, Larry Fox5, Christos J Petropoulus 6, Kenneth Lynn 1, Linden Lalley-Chareczko 7, Jay R. Kostman 8, William R. Short 1, KaramMounzer 7, Luis J. Montaner 2
1 UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA, USA | 2 THE WISTAR INSTITUTE, PHILADELPHIA, PA, USA | 3 ROCKEFELLER UNIVERSITY, NEW YORK, NY, USA| 4 MERCK, INC., WEST POINT, PA, USA | 5 NIAID, BETHESDA, MD,| USA | 6 MONOGRAM BIOSCIENCES, SOUTH SAN FRANCISCO, CA | 7 JONATHAN LAX IMMUNE DISORDERS TREATMENT CENTER, PHILADELPHIA FIGHT, PHILADELPHIA, PA, USA |8 JOHN BELL HEALTH CENTER, PHILADELPHIA FIGHT,
PHILADELPHIA, PA, USA
|
| |
|
|
|
|
|
